MEK-ing the most of it: strategies to co-target Galphaq and MAPK in uveal melanoma. Neelature Sriramareddy S, Smalley KSM. Clin Cancer Res 2020 Dec 22. pii: 1078-0432.CCR-20-4530.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Neelature Sriramareddy S, Smalley KSM. MEK-ing the most of it: strategies to co-target Galphaq and MAPK in uveal melanoma. Clin Cancer Res 2020 Dec 22. pii: 1078-0432.CCR-20-4530.
PMID: 33355300